On September 4, 2025, Medion underwent another virtual Good Manufacturing Practice (GMP) inspection by Pakistan’s Drug Regulatory Authority (DRAP) for its inactivated vaccine production facility. This inspection is part of the process to renew registrations for Medion’s existing products and
Virtual GMP Inspection by Pakistan’s Drug Regulatory Authority (DRAP) at PT Medion Farma Jaya
